Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bone Biologics Corp (BBLG)

Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bone Biologics Corp 2 BURLINGTON WOODS DRIVE SUITE 100 BURLINGTON MA 01803 USA

www.bonebiologics.com P: 781-552-4452

Description:

Bone Biologics Corp. is a developer of orthobiologic products for spine fusion markets. Bone Biologics Corp. is based in BURLINGTON, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,343
Enterprise Value, $K -1,687
Shares Outstanding, K 1,100
Annual Sales, $ 0 K
Annual Net Income, $ -8,950 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -870 K
EBIT, $ -7,180 K
EBITDA, $ -7,180 K
60-Month Beta 0.34
% of Insider Shareholders 13.00%
% of Institutional Shareholders 34.30%
Float, K 957
% Float 87.00%
Short Volume Ratio 0.20

Growth:

1-Year Return -89.68%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.31 on 05/14/24
Next Earnings Date 08/12/24
Earnings Per Share ttm -19.71
EPS Growth vs. Prev Year 97.63%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 12/20/23

BBLG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -151.99%
Return-on-Assets % -121.03%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.35
Book Value/Share 3.60
Interest Coverage -2.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar